What is CHE's five-year median EV/EBITDA?

18.5x. Half of CHE's weekly readings over the last five years were higher and half were lower. This page has 809 weekly readings, from Apr 25, 2011 to Oct 19, 2026.

Does a low historical rank mean a stock is a buy?

No. The rank compares CHE only with its own past. Slower growth or more risk can justify a lower multiple than before. P/E uses earnings and P/S uses revenue from the last twelve months.

Chemed Corp (CHE) valuation history

Health Care

$512.98

Latest weekly close · Market cap $6.8B

Below its usual range

As of Oct 24, 2026

CHE's EV/EBITDA of 16.5x is lower than 75% of its weekly readings over the last five years.

Weekly EV/EBITDA with its 5-year range

EV/EBITDA each weekMiddle half of the last 5 years5-year median 18.5×

5-year median: 18.5×
10-year median: 19.7×
5-year low to high: 13.0×–24.2×
Versus 5-year median: -11%

EV/EBITDA

25thpercentile

of its weekly readings over the last five years

Below its usual range

Growth, last 12 months vs the year before

Revenue: +3%slowing
EPS: +2%

Price vs revenue and EPS, indexed to 100

Each line starts at 100 at its first positive reading over the last five years. Revenue and EPS change at fiscal quarter ends.

PriceRevenue, last 12 monthsEPS, last 12 months100 = first reading

EV/EBITDA at each year-end

The last weekly reading of each year, and its percentile against the five years before it.

CHE EV/EBITDA at each year-end
Year-end	EV/EBITDA	5-year percentile
Dec 29, 2025	14.4×	2
Dec 30, 2024	18.5×	32
Dec 25, 2023	23.5×	84
Dec 26, 2022	18.5×	32
Dec 27, 2021	18.7×	31
Dec 28, 2020	22.6×	59
Dec 30, 2019	25.7×	84
Dec 31, 2018	17.3×	71
Dec 25, 2017	28.4×	99
Dec 26, 2016	13.1×	98

Health Care peers on EV/EBITDA

Each percentile compares a stock with its own last five years.

Compare CHE with peers

Health Care peers of CHE on EV/EBITDA
Stock	EV/EBITDA	Versus its own history	5-year percentile
CICigna	8.5×	Below its usual range	16
CVSCVS Health	13.0×	Above its usual range	78
DGXQuest Diagnostics	14.6×	Historically high	99
DVADaVita	7.9×	Within its usual range	49
GHGuardant Health Inc	n/a	Not ranked	n/a, not ranked

Appears in

Sector: Health Care
Screens: Stocks with Low P/E Ratios and Steady Revenue Growth
Stocks Below Their 5-Year Median P/E
Stocks Near Their Lowest P/E Ratios in 5 Years

Screen Health Care stocks the same way

Research on CHE

No articles about CHE yet. How valuation percentiles work

Loading peers and related research…

About this history

What is CHE's current EV/EBITDA?: CHE's EV/EBITDA of 16.5x is lower than 75% of its weekly readings over the last five years.
What is CHE's five-year median EV/EBITDA?: 18.5x. Half of CHE's weekly readings over the last five years were higher and half were lower. This page has 809 weekly readings, from Apr 25, 2011 to Oct 19, 2026.
Does a low historical rank mean a stock is a buy?: No. The rank compares CHE only with its own past. Slower growth or more risk can justify a lower multiple than before. P/E uses earnings and P/S uses revenue from the last twelve months.